How is the Clene Inc today?

The Clene Inc today is trading in the down by -1.85% at 4.25.

What is Clene Inc Annual Revenue?

Clene Inc Annual Revenue fell 47.71%, in the last year to $0.34 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Clene Inc Annual Net Profit?

Clene Inc Annual Net Profit rose 20.41% in the last year to $39.4 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Clene Inc Price to Earning Ratio?

Clene Inc Price to Earning Ratio is -1.31, which is negative.

What is Clene Inc Stock Price?

Clene Inc Stock Price fell 39.46% and underperformed its sector by 72.15% in the past year.

What is Clene Inc Quarterly Revenue?

Clene Inc Quarterly Revenue rose 10.96% YoY to $0.08 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Clene Inc Quarterly Net profit?

Clene Inc Quarterly Net profit rose 93.22% YoY to $0.75 M. Its sector's average net profit growth YoY for the quarter was -239.15%.

What is Clene Inc Return on Equity(ROE)?

Clene Inc Return on Equity(ROE) for the last financial year was -1,738.36%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Clene Inc Mutual Fund Holding?

Clene Inc Mutual Fund Holding decreased by 0.05% in the last quarter to 4.26.

What is Clene Inc Interest Coverage Ratio?

Clene Inc Interest Coverage Ratio is -8.69, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Clene Inc Institutional Holding?

Clene Inc Institutional Holding decreased by 0.42% in the last quarter to 5.76.

Clene Inc XNAS: CLNN

Clene Inc Live Share Price Today, Share Analysis and Chart

Name: Clene Inc: Is Infosys Ltd. worth buying?
Item: Clene Inc
Rating: 1.38016675
Author: Trendlyne DVM scores

about

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseas...

4.25 -0.08 (-1.85%)

53.80% Fall from 52W High

84,881 XNAS Volume

High vol.+gain this week

XNAS 06 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

1.7 / 100

Technically Neutral

53.5 / 100

28

1Yr Price target upside is 555%

6 analysts

Clene Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Clene Inc FAQ

How is Clene Inc today?

Clene Inc today is trading in the red, and is down by -1.85% at 4.25.

How has Clene Inc performed historically?

Clene Inc is currently trading down -1.85% on an intraday basis. In the past week the stock rose 33.23%. stock has been down -6.18% in the past quarter and fell -39.46% in the past year. You can view this in the overview section.